EU Taxonomy for Healthcare

What is EU Taxonomy?

The EU Taxonomy is a classification system established by the European Union through Regulation (EU) 2020/852, designed to define which economic activities can be considered environmentally sustainable. It provides a common language for investors, companies, and policymakers to identify investments that genuinely contribute to climate and environmental goals. By setting clear, science-based criteria, the EU Taxonomy aims to redirect capital flows toward a more sustainable European economy and prevent greenwashing.

EU Taxonomy and the Healthcare Industry

The healthcare sector occupies a unique position under the EU Taxonomy framework. While its primary social mission — caring for human health — is indisputable, the industry carries a significant environmental footprint that regulators are increasingly scrutinizing. Hospitals, pharmaceutical manufacturers, medical device producers, and private clinic operators all consume substantial energy, generate considerable waste, and rely on complex, often carbon-intensive supply chains.

For healthcare companies, the relevance of the EU Taxonomy is twofold. First, any organization that is subject to the Non-Financial Reporting Directive (NFRD) or its successor, the Corporate Sustainability Reporting Directive (CSRD), must disclose what proportion of their turnover, capital expenditure (CapEx), and operating expenditure (OpEx) is aligned with the Taxonomy. Second, healthcare companies seeking green financing — such as green bonds or sustainability-linked loans — must demonstrate Taxonomy alignment to access favorable terms from institutional investors.

A large hospital network, for example, that invests in a new energy-efficient building must assess whether that construction project meets the Taxonomy criteria for "Construction and real estate activities." A pharmaceutical company commissioning a new manufacturing facility powered by renewable energy can potentially classify that investment as Taxonomy-aligned under the criteria for low-carbon industrial production. Similarly, a private health clinic that retrofits its existing premises to significantly improve energy performance can report the associated OpEx as contributing to Taxonomy-aligned activities under the environmental objective of climate change mitigation.

The healthcare sector is also directly referenced in discussions around the "substantial contribution" criteria for the social Taxonomy, which is currently under development. Until then, healthcare companies must primarily focus on the six environmental objectives: climate change mitigation, climate change adaptation, sustainable use of water, transition to a circular economy, pollution prevention, and protection of biodiversity.

Key Requirements

To claim Taxonomy alignment, a healthcare company must demonstrate that a given economic activity meets three cumulative conditions. Below are the principal requirements applied specifically to the healthcare context:

• Substantial Contribution to at Least One Environmental Objective: The activity must make a meaningful positive contribution to one of the six EU environmental objectives. For most healthcare organizations, the most relevant objectives are climate change mitigation — for example, reducing the energy consumption of hospital buildings — and climate change adaptation, such as redesigning facilities to withstand increased heat stress or flooding risks linked to climate change.
• Do No Significant Harm (DNSH) to Other Objectives: Even if an activity contributes substantially to one objective, it must not cause serious harm to any of the remaining five. A healthcare company installing a combined heat and power plant must ensure, for instance, that the project does not lead to increased water pollution or undermine local biodiversity.
• Minimum Social Safeguards: The activity must be carried out in compliance with minimum standards relating to human rights, labor rights, anti-corruption, and fair taxation, as defined by international frameworks such as the OECD Guidelines for Multinational Enterprises and the UN Guiding Principles on Business and Human Rights. Healthcare employers must demonstrate adherence to these standards across their workforce and supply chains.
• Technical Screening Criteria (TSC) Compliance: Each eligible activity has specific, quantitative thresholds. For the renovation of hospital buildings, this means achieving a minimum reduction in primary energy demand — typically 30% compared to pre-renovation performance — supported by energy audits and documented performance data.
• Eligible Activity Classification: Only economic activities listed in the Delegated Acts under the Taxonomy Regulation are eligible. Healthcare companies must carefully map their revenue streams and investments against the NACE codes specified in the legislation. Construction, energy generation, and transport are among the most commonly relevant categories for the sector.
• Robust Data Collection and Audit Trail: Companies must be able to substantiate all Taxonomy claims with verifiable evidence. This includes energy performance certificates, third-party audit reports, emissions inventories, and internal financial records that clearly separate aligned from non-aligned CapEx and OpEx.
• Proportional Disclosure in Non-Financial Reporting: Organizations within the CSRD scope must include Taxonomy KPIs — turnover ratio, CapEx ratio, and OpEx ratio — in their sustainability reports. Healthcare companies should establish internal accounting methodologies that allow these ratios to be calculated consistently year over year.

Implementation Steps for Healthcare Companies

1. Determine Reporting Obligations: Establish whether your organization falls within the scope of the CSRD or NFRD. Companies with more than 250 employees, a net turnover exceeding 40 million euros, or total assets exceeding 20 million euros are generally in scope. Large hospital groups, national pharmacy chains, and multinational medical device companies will typically be required to report Taxonomy KPIs.
2. Map Economic Activities to NACE Codes: Conduct a systematic review of all revenue-generating activities and capital investments. Identify which activities correspond to eligible NACE codes listed in the EU Taxonomy Delegated Acts. For a hospital group, this might include construction of new facilities (NACE F section), operation of renewable energy installations (NACE D35.1), or transport fleet electrification (NACE H49.3).
3. Assess Substantial Contribution: For each identified eligible activity, evaluate whether it meets the quantitative technical screening criteria. Engage energy auditors, environmental consultants, or internal sustainability teams to gather the necessary performance data. A building renovation project, for instance, will require a certified energy performance assessment before and after the works.
4. Conduct a DNSH Assessment: For every activity that passes the substantial contribution test, perform a Do No Significant Harm analysis across the remaining five environmental objectives. Document the assessment methodology and conclusions. This step often requires cross-functional collaboration between facilities management, procurement, legal, and sustainability departments.
5. Verify Minimum Social Safeguards: Review your organization's compliance with the referenced international standards. This typically involves an audit of labor practices, supplier conduct codes, and governance policies. Healthcare organizations with complex, global medical supply chains will need to extend this review beyond direct operations to key suppliers.
6. Calculate and Validate Taxonomy KPIs: Using the verified data from previous steps, calculate the three Taxonomy ratios — turnover, CapEx, and OpEx alignment percentages. Establish clear internal accounting rules that define what counts as aligned and maintain consistent definitions across reporting periods. Consider engaging an external assurance provider to validate the KPIs before publication.
7. Integrate into Sustainability Reporting: Incorporate Taxonomy disclosures into your annual sustainability or non-financial report in the format required under the European Sustainability Reporting Standards (ESRS). Ensure that the narrative explanation accompanying the KPIs provides sufficient context, including the specific activities classified as aligned and the screening criteria applied.
8. Build Internal Capability and Governance: Establish a dedicated working group or assign clear ownership for ongoing Taxonomy compliance. As the Taxonomy framework evolves — particularly with the anticipated expansion to social objectives — your organization will need the institutional knowledge and processes to adapt disclosures accordingly. Regular internal training for finance, legal, and operations teams is essential to maintain accuracy and consistency.

Frequently Asked Questions

Does the EU Taxonomy apply to all healthcare companies, including small private clinics?

The mandatory disclosure requirements under the CSRD currently apply to large companies that meet specific size thresholds — more than 250 employees or significant financial turnover and balance sheet totals — as well as to listed small and medium-sized enterprises on regulated EU markets. A small private clinic with fewer than 50 employees is not directly required to report Taxonomy KPIs. However, small healthcare providers may still be indirectly affected if they are part of the supply chain of a larger reporting entity or if they seek green financing from investors who require Taxonomy-aligned information as part of their due diligence.

What specific activities in the healthcare sector are most likely to qualify as Taxonomy-aligned?

The activities most commonly assessed for Taxonomy alignment in the healthcare sector include energy-efficient renovation of existing hospital and clinic buildings, installation of on-site renewable energy generation such as solar panels on hospital rooftops, electrification of patient transport or delivery vehicle fleets, and construction of new healthcare facilities built to near-zero energy standards. It is important to note that the core clinical activity of providing medical care does not itself currently appear as an eligible activity in the published Delegated Acts — alignment is therefore assessed at the level of supporting infrastructure and operational activities rather than the healthcare service itself.

How does the "Do No Significant Harm" principle affect pharmaceutical manufacturing?

Pharmaceutical manufacturers face particular scrutiny under the DNSH principle, especially with respect to water and pollution objectives. The production of active pharmaceutical ingredients is known to generate hazardous chemical waste and effluents that can contaminate water systems. A pharmaceutical company claiming Taxonomy alignment for a new energy-efficient manufacturing facility must demonstrate that its wastewater treatment processes meet or exceed applicable EU environmental standards, that hazardous substances are managed in accordance with REACH and related regulations, and that the facility does not negatively impact local water bodies or soil quality. Failing to meet even one DNSH criterion is sufficient to disqualify the entire activity from being classified as Taxonomy-aligned.

How should a healthcare company handle activities that are only partially aligned with the Taxonomy?

Partial alignment is a common scenario. For example, a hospital group may invest in a new wing that meets energy performance criteria but where certain elements of the construction do not yet meet DNSH requirements for biodiversity. In such cases, the company cannot classify the entire investment as Taxonomy-aligned. Instead, it may be possible to apply a proportional approach — documenting which specific portions of the CapEx meet all three conditions and reporting those as aligned while classifying the remainder as non-aligned or Taxonomy-eligible but not yet aligned. Transparency in the reporting methodology is critical, and companies should clearly explain the basis for any proportional calculations in their sustainability disclosures.

Summary

The EU Taxonomy represents both a compliance obligation and a strategic opportunity for healthcare companies committed to operating sustainably. Organizations that invest in energy-efficient infrastructure, clean energy, and responsible supply chain management today will be well-positioned to report strong Taxonomy alignment ratios, attract green capital, and meet the rising expectations of patients, regulators, and institutional investors. The path to Taxonomy alignment requires methodical preparation — from mapping activities to NACE codes and conducting DNSH assessments to building robust internal reporting processes — but healthcare companies that begin this work now will secure a competitive and regulatory advantage as sustainability disclosure requirements continue to tighten across Europe.